DE2449530C2 - Virusuntereinheitenimpfstoff - Google Patents

Virusuntereinheitenimpfstoff

Info

Publication number
DE2449530C2
DE2449530C2 DE2449530A DE2449530A DE2449530C2 DE 2449530 C2 DE2449530 C2 DE 2449530C2 DE 2449530 A DE2449530 A DE 2449530A DE 2449530 A DE2449530 A DE 2449530A DE 2449530 C2 DE2449530 C2 DE 2449530C2
Authority
DE
Germany
Prior art keywords
virus
vol
vaccine
surfactant
gradient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2449530A
Other languages
German (de)
English (en)
Other versions
DE2449530A1 (de
Inventor
Margaret Irene Lydiate Lancashire Brady
Ian George Stephen West Kirby Wirral Merseyside Furminger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma Ltd
Original Assignee
Duncan Flockhart Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duncan Flockhart Co Ltd filed Critical Duncan Flockhart Co Ltd
Publication of DE2449530A1 publication Critical patent/DE2449530A1/de
Application granted granted Critical
Publication of DE2449530C2 publication Critical patent/DE2449530C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE2449530A 1973-10-18 1974-10-17 Virusuntereinheitenimpfstoff Expired DE2449530C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB48685/73A GB1486557A (en) 1973-10-18 1973-10-18 Process for the preparation of pyrogen-free sub-unit vaccine

Publications (2)

Publication Number Publication Date
DE2449530A1 DE2449530A1 (de) 1975-04-30
DE2449530C2 true DE2449530C2 (de) 1985-08-08

Family

ID=10449549

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2449530A Expired DE2449530C2 (de) 1973-10-18 1974-10-17 Virusuntereinheitenimpfstoff

Country Status (15)

Country Link
JP (1) JPS5082228A (US20100268047A1-20101021-C00003.png)
AT (1) AT334524B (US20100268047A1-20101021-C00003.png)
BE (1) BE821175A (US20100268047A1-20101021-C00003.png)
CA (1) CA1050886A (US20100268047A1-20101021-C00003.png)
CH (1) CH611518A5 (US20100268047A1-20101021-C00003.png)
DE (1) DE2449530C2 (US20100268047A1-20101021-C00003.png)
DK (1) DK138581B (US20100268047A1-20101021-C00003.png)
FR (1) FR2248054B1 (US20100268047A1-20101021-C00003.png)
GB (1) GB1486557A (US20100268047A1-20101021-C00003.png)
IE (1) IE40187B1 (US20100268047A1-20101021-C00003.png)
IL (1) IL45870A (US20100268047A1-20101021-C00003.png)
NL (1) NL181553C (US20100268047A1-20101021-C00003.png)
NO (1) NO142024C (US20100268047A1-20101021-C00003.png)
SE (1) SE426439B (US20100268047A1-20101021-C00003.png)
ZA (1) ZA746398B (US20100268047A1-20101021-C00003.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK276380A (da) * 1979-07-09 1981-01-10 Univ Iowa State Res Found Inc Fremgangsmaade til fremstilling af en vaccine mod infektioes kvaeg-rhinotracheitis
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
FR2475572A1 (fr) * 1980-02-11 1981-08-14 Pasteur Institut Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
FR2483779A1 (fr) 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
PL362964A1 (en) * 2000-10-02 2004-11-02 Glaxosmithkline Biologicals S.A. Vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
DK138581C (US20100268047A1-20101021-C00003.png) 1979-03-12
SE426439B (sv) 1983-01-24
NL7413642A (nl) 1975-04-22
NO142024B (no) 1980-03-10
CH611518A5 (en) 1979-06-15
DK543974A (US20100268047A1-20101021-C00003.png) 1975-06-16
BE821175A (fr) 1975-04-17
AT334524B (de) 1976-01-25
DK138581B (da) 1978-10-02
NO743758L (US20100268047A1-20101021-C00003.png) 1975-05-12
IE40187L (en) 1975-04-18
CA1050886A (en) 1979-03-20
ZA746398B (en) 1976-06-30
GB1486557A (en) 1977-09-21
DE2449530A1 (de) 1975-04-30
JPS5082228A (US20100268047A1-20101021-C00003.png) 1975-07-03
NL181553B (nl) 1987-04-16
ATA835074A (de) 1976-05-15
NL181553C (nl) 1987-09-16
IE40187B1 (en) 1979-03-28
FR2248054A1 (US20100268047A1-20101021-C00003.png) 1975-05-16
IL45870A0 (en) 1974-12-31
AU7444974A (en) 1976-04-29
FR2248054B1 (US20100268047A1-20101021-C00003.png) 1978-07-28
NO142024C (no) 1980-06-18
IL45870A (en) 1978-03-10
SE7413113L (US20100268047A1-20101021-C00003.png) 1975-04-21

Similar Documents

Publication Publication Date Title
DE69732407T2 (de) Verfahren für die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
DE69634960T2 (de) Stabilisatoren für lebendimpfstoffe
DE10144906A1 (de) Verfahren zur Herstellung eines aktiven Bestandteils eines Arznei- oder Diagnosemittels in MDCK-Zell-Suspensionskultur
Waterson et al. The components of measles virus and their relation to rinderpest and distemper
DE2449530C2 (de) Virusuntereinheitenimpfstoff
DE69232969T2 (de) Methode zur herstellung von gram-negativen bakteriellen vakzinen
US4158054A (en) Preparation of virus sub-unit vaccines
EP0041880B1 (fr) Procédé pour isoler des antigènes glycoprotéiques viraux et son application à la préparation de vaccins
DE2423129A1 (de) Verfahren zur herstellung temperaturempfindlicher, nicht pathogener mutantenstaemme von rinder-adeno-virusstaemmen und diese virusstaemme enthaltende lebendvakzine
DE2405675A1 (de) Verfahren zur inaktivierung von viren und die herstellung von vakzinen
DD155875A1 (de) Verfahren zur herstellung eines ballaststoffarmen inaktivierten influenzaimpfstoffes
EP0222974B1 (de) Verfahren zur Herstellung eines Tollwutimpfstoffes und nach diesem Verfahren erhaltener Impfstoff
DE2500785C3 (US20100268047A1-20101021-C00003.png)
DE2829089A1 (de) Subunit-vakzine
DE2456636A1 (de) Influenza-vakzine und verfahren zu ihrer herstellung
DE3005495C2 (de) Herstellung von Fragmenten von Viren mit Lipidhülle und sie enthaltende Arzneimittelzubereitungen
CH644271A5 (de) Verfahren zur herstellung von fruehsommer-meningoenzephalitis-virus-vakzinen.
DE2041647A1 (de) Zellreihe aus der Leber menschlicher Embryonen,Verfahren zu deren Herstellung und deren Verwendung
DE3009064C2 (de) Verfahren zur Herstellung eines Tollwutimpfstoffes
US2720484A (en) Process for separation of viral substances from animal tissues
DE2440927A1 (de) Verfahren zur herstellung von aktivierten hb-ag-vaccinen
DE2045160B2 (de) Verfahren zur Herstellung einer Lebendvaccine gegen die infektiöse Bursitis der Hühner
DE2111120C3 (de) Verfahren zur Herstellung von Rubella-Virus-Hämagglutinationsantigen
AT231068B (de) Verfahren zur Herstellung von Vaccinzwischenprodukten
DE2132911C2 (de) Verfahren zum Herstellen eines stark abgeschwächte Rötelviren enthaltenden Impfstoffs

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ZUMSTEIN SEN., F., DR. ASSMANN, E., DIPL.-CHEM. DR

D2 Grant after examination
8380 Miscellaneous part iii

Free format text: PATENTANSPRUCH 1, ZEILE 5 "INKRAFTTRETEN" AENDERN IN "INAKTIVIEREN"

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: EVANS MEDICAL LTD., GREENFORD, GB

8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT